menu
    • menu

    Company profile for Dova Pharmaceuticals

    NEW Drugs in Dev: 1
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Dova is a clinical-stage pharmaceutical company focused on acquiring, developing and commercializing drug candidates for diseases where there is a high unmet medical need. With a nimble approach and a team of bright minds aglow with passion, we’re dedicated to bringing brilliant medicine to market.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Dova PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    240 Leigh Farm Road Suite 245 Durham, NC 27707
    Telephone
    Telephone
    +1-844-506-3682
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://dova.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/dova-pharmaceuticals/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sobi boosts hematology sales with growth across key brands
    Sobi boosts hematology sales with growth across key brands

    16 Jul 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/sobi-angling-become-major-hematology-player-sees-momentum-across-key-brands

    FIERCE PHARMA
    16 Jul 2024
    Share Share
    Dova Announces DOPTELET® (avatrombopag) Data Presentations at Upcoming 62nd ASH
    Dova Announces DOPTELET® (avatrombopag) Data Presentations at Upcoming 62nd ASH

    01 Dec 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/dova-announces-doptelet-avatrombopag-data-presentations-at-upcoming-62nd-american-society-of-hematology-annual-meeting-and-exposition-301179444.html

    PRNEWSWIRE
    01 Dec 2020
    Share Share
    Dova Granted Orphan Drug Designation for Avatrombopag
    Dova Granted Orphan Drug Designation for Avatrombopag

    13 Jan 2020

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/dova-granted-orphan-drug-designation-for-avatrombopag-for-the-treatment-of-chemotherapy-induced-thrombocytopenia-300985361.html

    PR NEWSWIRE
    13 Jan 2020
    Share Share
    Additional Analyses From Phase 3 study With Doptelet ® (avatrombopag)
    Additional Analyses From Phase 3 study With Doptelet ® (avatrombopag)

    09 Dec 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/additional-analyses-from-phase-3-study-with-doptelet--avatrombopag-for-the-treatment-of-chronic-immune-thrombocytopenia-provides-evidence-of-long-term-response-rates-300971110.html

    PR NEWSWIRE
    09 Dec 2019
    Share Share
    Sobi Successfully Completes Acquisition of Dova Pharmaceuticals
    Sobi Successfully Completes Acquisition of Dova Pharmaceuticals

    13 Nov 2019

    // BIOSPACE

    https://www.biospace.com/article/releases/sobi-successfully-completes-acquisition-of-dova-pharmaceuticals/?s=79

    BIOSPACE
    13 Nov 2019
    Share Share
    Sobi finds another fit for its dealmaking strategy
    Sobi finds another fit for its dealmaking strategy

    01 Oct 2019

    // Jacob Bell BIOPHARMADIVE

    https://www.biopharmadive.com/news/sobi-acquires-dova-doptelet-rare-disease-hematology/564004/

    Jacob Bell BIOPHARMADIVE
    01 Oct 2019
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search